Minesapride

DB20801ExperimentalSmall molecule

Minesapride is a small molecule drug. The usage of the INN stem '-pride' in the name indicates that Minesapride is a sulpiride derivative and analogue. Minesapride has a monoisotopic molecular...

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 4
Curator reviewed
Formula / weight: C₂₁H₃₁ClN₄O₅ · 454.95 g/mol (avg)

Resolves to

Compound

UNIII7V9UD0ND0CAS1184662-54-1

Structure

InChIKeyYNGWOFISMAAXPB-HNNXBMFYSA-NSMILESCOC1=C(C=C(Cl)C(N)=C1)C(=O)NC[C@H]1CN(CC2CCN(CC2)C(=O)CO)CCO1

Targets

Q13639HTR4

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Minesapride, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account